Inspira Pharma is developing a potential new therapy for COVID-19. The active molecules being tested are plant-based and have shown an ability to destroy the SARS-CoV-2 virus in the lab. Funds raised will be used to test clinical formulations and prove safety and efficacy in humans.
Wholesale of pharmaceutical goods
|Date||Amount||No. of Investors|
|MCGOLDRICK, Rory James||Director||21/01/2021||Australian|
|WOOLF, Nicholas Leslie||Director||20/11/2020||British|